APA (7th ed.) Citation

Cancer, E. O. o. C. J. o. L. Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report. Chinese Anti-Cancer Association; Chinese Antituberculosis Association.

Chicago Style (17th ed.) Citation

Cancer, Editorial Office of Chinese Journal of Lung. Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report. Chinese Anti-Cancer Association; Chinese Antituberculosis Association.

MLA (9th ed.) Citation

Cancer, Editorial Office of Chinese Journal of Lung. Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report. Chinese Anti-Cancer Association; Chinese Antituberculosis Association.